Cite
Patient-reported outcomes in transition from high-dose U-100 insulin to human regular U-500 insulin in severely insulinresistant patients with type 2 diabetes: analysis of a randomized clinical trial.
MLA
Kabul, Samaneh, et al. “Patient-Reported Outcomes in Transition from High-Dose U-100 Insulin to Human Regular U-500 Insulin in Severely Insulinresistant Patients with Type 2 Diabetes: Analysis of a Randomized Clinical Trial.” Health & Quality of Life Outcomes, vol. 14, Sept. 2016, pp. 1–9. EBSCOhost, https://doi.org/10.1186/s12955-016-0541-4.
APA
Kabul, S., Hood, R. C., Duan, R., DeLozier, A. M., & Settles, J. (2016). Patient-reported outcomes in transition from high-dose U-100 insulin to human regular U-500 insulin in severely insulinresistant patients with type 2 diabetes: analysis of a randomized clinical trial. Health & Quality of Life Outcomes, 14, 1–9. https://doi.org/10.1186/s12955-016-0541-4
Chicago
Kabul, Samaneh, Robert C. Hood, Ran Duan, Amy M. DeLozier, and Julie Settles. 2016. “Patient-Reported Outcomes in Transition from High-Dose U-100 Insulin to Human Regular U-500 Insulin in Severely Insulinresistant Patients with Type 2 Diabetes: Analysis of a Randomized Clinical Trial.” Health & Quality of Life Outcomes 14 (September): 1–9. doi:10.1186/s12955-016-0541-4.